1 |
MalireddiRKS, KesavardhanaS, KannegantiTD.ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis)[J].Front Cell Infect Microbiol,2019 (9):406.
|
2 |
SamirP, MalireddiRKS, KannegantiTD.The PANop-tosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis)[J].Front Cell Infect Microbiol,2020 (10):238.
|
3 |
ChristgenS, ZhengM, KesavardhanaS,et al.Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis)[J].Front Cell Infect Microbiol,2020 (10):237.
|
4 |
PlaceDE, KannegantiTD.The innate immune system and cell death in autoinflammatory and autoimmune disease[J].Curr Opin Immunol,2020 (67):95-105.
|
5 |
KawaiT, AkiraS.Signaling to NF-kappaB by Toll-like receptors[J].Trends Mol Med,2007,13 (11):460-469.
|
6 |
LiX, JiangS, TappingRI.Toll-like receptor signaling in cell proliferation and survival[J].Cytokine,2010,49(1):1-9.
|
7 |
ThapaRJ, BasagoudanavarSH, NogusaS,et al.NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis[J].Mol Cell Biol,2011,31 (14):2934-2946.
|
8 |
PhilipNH, DillonCP, SnyderAG,et al.Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling[J].Proc Natl Acad Sci U S A,2014,111 (20):7385-7390.
|
9 |
KaiserWJ, SridharanH, HuangC,et al.Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL[J].J Biol Chem,2013,288 (43):31268-31279.
|
10 |
ZhengM, KarkiR, VogelP,et al.Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense[J].Cell,2020,181 (3):674-687.
|
11 |
ZhengM, KannegantiTD.Newly identified function of caspase-6 in ZBP1-mediated innate immune responses, NLRP3 inflammasome activation, PANoptosis, and host defense[J].J Cell Immunol,2020,2 (6):341-347.
|
12 |
MalireddiRKS, GurungP, MavuluriJ,et al.TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation[J].J Exp Med,2018,215 (4):1023-1034.
|
13 |
OrningP, WengD, StarheimK,et al.Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death[J].Science,2018,362 (6418):1064-1069.
|
14 |
SarhanJ, LiuBC, MuendleinHI,et al.Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during infection[J].Proc Natl Acad Sci U S A,2018,115 (46):E10888-E10897.
|
15 |
KarkiR, SharmaBR, TuladharS,et al.Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes[J].Cell,2021,184 (1):149-168.e17.
|
16 |
KuriakoseT, ManSM, MalireddiRK,et al.ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways[J].Sci Immunol,2016,1 (2):aag2045.
|
17 |
ZhengM, WilliamsEP, MalireddiRKS,et al.Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection[J].J Biol Chem,2020,295 (41):14040-14052.
|
18 |
LaceyCA, MiaoEA.Programmed cell death in the evolutionary race against bacterial virulence factors[J].Cold Spring Harb Perspect Biol,2020,12 (2):a036459.
|
19 |
MalireddiRKS, KesavardhanaS, KarkiR,et al.RIPK1 distinctly regulates Yersinia-induced inflammatory cell death, PANoptosis[J].Immunohorizons,2020,4 (12):789-796.
|
20 |
ManSM, HopkinsLJ, NugentE,et al.Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex[J].Proc Natl Acad Sci U S A,2014,111 (20):7403-7408.
|
21 |
KankkunenP, TeirilaL, RintahakaJ,et al.(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages[J].J Immunol,2010,184 (11):6335-6342.
|
22 |
GanesanS, RathinamVAK, BossallerL,et al.Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans[J].J Immunol,2014,193 (5):2519-2530.
|
23 |
KarkiR, SharmaBR, LeeE,et al.Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer[J].JCI insight,2020,5 (12):e136720.
|
24 |
AllenIC, TeKippeEM, WoodfordRM,et al.The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer[J].J Exp Med,2010,207 (5):1045-1056.
|
25 |
BauerC, DuewellP, LehrHA,et al.Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors[J].Dig Dis,2012 (30Suppl 1):82-90.
|
26 |
ZakiMH, BoydKL, VogelP,et al.The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis[J].Immunity,2010,32 (3):379-391.
|
27 |
ZakiMH, VogelP, Body-MalapelM,et al.IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation[J].J Immunol,2010,185 (8):4912-4920.
|
28 |
BauerC, DuewellP, MayerC,et al.Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome[J].Gut,2010,59(9):1192-1199.
|
29 |
Dupaul-ChicoineJ, ArabzadehA, DagenaisM,et al.The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity[J].Immunity,2015,43 (4):751-763.
|
30 |
ChowMT, SceneayJ, PagetC,et al.NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases[J].Cancer Res,2012,72 (22):5721-5732.
|
31 |
van DeventerHW, BurgentsJE, WuQP,et al.The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells[J].Cancer Res,2010,70 (24):10161-10169.
|
32 |
LiuW, LuoY, DunnJH,et al.Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma[J].J Invest Dermatol,2013,133 (2):518-527.
|
33 |
DrexlerSK, BonsignoreL, MasinM,et al.Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis[J].Proc Natl Acad Sci U S A,2012,109 (45):18384-18389.
|
34 |
SatoS, SanjoH, TakedaK,et al.Essential function for the kinase TAK1 in innate and adaptive immune responses[J].Nat Immunol,2005,6 (11):1087-1095.
|
35 |
LamotheB, LaiY, HurL,et al.Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice[J].PLoS one,2012,7 (12):e51228.
|
36 |
XuD, JinT, ZhuH,et al.TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging[J].Cell,2018,174 (6):1477-1491.e19.
|
37 |
EftychiC, KaragianniN, AlexiouM,et al.Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia[J].PLoS one,2012,7 (2):e31550.
|